Search
for
Sort by
Research 241–270 of 1000+
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Cedrol restricts the growth of colorectal cancer <i>in vitro</i> and<i> in vivo</i> by inducing cell cycle arrest and caspase-dependent apoptotic cell death
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Finasteride en el año 2006
- Oral minoxidil for late alopecia in cancer survivors
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Wnt signaling: the good and the bad
- Forearm hair density and risk of keratinocyte cancers in Australian adults
- Environmental factors influencing hormone receptor positive breast cancer incidence: integrating chemical signatures from dust wipes with self-reported sources of exposure
- COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome
- Icariside II inhibits gastric cancer progression by suppressing the Wnt/β-catenin signaling pathway
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
- Oncogenic senescence: a multi-functional perspective
- A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Association of Spironolactone Use With Risk of Cancer
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer